T20-M

T20-M is a lead peptide that shows good potential for binding affinity towards UBE2C[1].

Product Specifications

UNSPSC

12352209

Target

Deubiquitinase

Related Pathways

Cell Cycle/DNA Damage

Field of Research

Cancer

Smiles

O=C(N[C@@H](CC(C)C)C(NCC(N[C@@H](CCC(O)=O)C(N[C@@H]([C@H](O)C)C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H](CC2=CC=C(C=C2)O)C(N[C@@H](CCC(N)=O)C(N[C@@H](C)C(N[C@@H](CCSC)C(N[C@@H](CC(C)C)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC(N)=O)C(N[C@@H](CC(C)C)C(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC(C)C)N

Molecular Formula

C87H140N22O26S

Molecular Weight

1942.24

References & Citations

[1]Añonuevo AM, et al. In silico de novo drug design of a therapeutic peptide inhibitor against UBE2C in breast cancer. J Bioinform Comput Biol. 2023 Feb;21 (1) :2250029.